Arteriocyte Approved to Move Forward With Critical Limb Ischemia Trial

Arteriocyte announced approval from the Food and Drug Administration to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb Ischemia.
CNBC